Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)

R K Ismail; F M N H Schramel; M van Dartel; A M G Pasmooij; C M Cramer-van der Welle; D L Hilarius; A de Boer; M W J M Wouters; E M W van de Garde

doi:10.1186/s12874-023-01850-7

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)

R K Ismail, F M N H Schramel, M van Dartel, A M G Pasmooij, C M Cramer-van der Welle, D L Hilarius, A de Boer, M W J M Wouters, E M W van de Garde

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.

Original language	English
Article number	26
Journal	BMC Medical Research Methodology
Volume	23
Issue number	1
DOIs	https://doi.org/10.1186/s12874-023-01850-7
Publication status	Published - 27 Jan 2023

Access to Document

10.1186/s12874-023-01850-7Licence: CC BY

s12874-023-01850-7Final published version, 635 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)'. Together they form a unique fingerprint.

Cite this

Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., der Welle, C. M. C., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., & van de Garde, E. M. W. (2023). Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0). BMC Medical Research Methodology, 23(1), Article 26. https://doi.org/10.1186/s12874-023-01850-7

@article{a4701daf50914de1b9cea7c9eb567d35,

title = "Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)",

abstract = "Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.",

author = "Ismail, \{R K\} and Schramel, \{F M N H\} and \{van Dartel\}, M and Pasmooij, \{A M G\} and \{der Welle\}, \{C M Cramer-van\} and Hilarius, \{D L\} and \{de Boer\}, A and Wouters, \{M W J M\} and \{van de Garde\}, \{E M W\}",

year = "2023",

month = jan,

day = "27",

doi = "10.1186/s12874-023-01850-7",

language = "English",

volume = "23",

journal = "BMC Medical Research Methodology",

issn = "1471-2288",

publisher = "BioMed Central",

number = "1",

}

Ismail, RK, Schramel, FMNH, van Dartel, M, Pasmooij, AMG, der Welle, CMC, Hilarius, DL, de Boer, A, Wouters, MWJM & van de Garde, EMW 2023, 'Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)', BMC Medical Research Methodology, vol. 23, no. 1, 26. https://doi.org/10.1186/s12874-023-01850-7

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0). / Ismail, R K; Schramel, F M N H; van Dartel, M et al.
In: BMC Medical Research Methodology, Vol. 23, No. 1, 26, 27.01.2023.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction

T2 - Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)

AU - Ismail, R K

AU - Schramel, F M N H

AU - van Dartel, M

AU - Pasmooij, A M G

AU - der Welle, C M Cramer-van

AU - Hilarius, D L

AU - de Boer, A

AU - Wouters, M W J M

AU - van de Garde, E M W

PY - 2023/1/27

Y1 - 2023/1/27

N2 - Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.

AB - Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.

UR - https://www.scopus.com/pages/publications/85146941930

U2 - 10.1186/s12874-023-01850-7

DO - 10.1186/s12874-023-01850-7

M3 - Comment/Letter to the editor

C2 - 36707787

SN - 1471-2288

VL - 23

JO - BMC Medical Research Methodology

JF - BMC Medical Research Methodology

IS - 1

M1 - 26

ER -

Ismail RK, Schramel FMNH, van Dartel M, Pasmooij AMG, der Welle CMC, Hilarius DL et al. Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0). BMC Medical Research Methodology. 2023 Jan 27;23(1):26. doi: 10.1186/s12874-023-01850-7

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this